The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of IM156, a novel potent biguanide oxidative phosphorylation (OXPHOS) inhibitor, in patients with advanced solid tumors.
 
Sun Young Rha
Consulting or Advisory Role - Abbvie; Daiichi Sankyo; Eisai; Ipsen; MSD Oncology; Novartis
Speakers' Bureau - Ipsen; Lilly
Research Funding - ASLAN Pharmaceuticals; Bayer; Bristol-Myers Squibb; Cellid; Eisai; Immunome; medpacto; MSD Oncology; Roche/Genentech; Sillajen
 
Seung-Hoon Beom
No Relationships to Disclose
 
Young Geun Shin
Consulting or Advisory Role - Immunome
 
Dong-Seok Yim
Stock and Other Ownership Interests - AIM BioSciences; Q-fitter
Consulting or Advisory Role - Q-fitter
 
Yong Wha Moon
Research Funding - Immunome
 
Tae Won Kim
Employment - Asan Medical Center
Research Funding - AstraZeneca (Inst); Merck Serono (Inst); Sanofi (Inst)
 
Sun Young Kim
Research Funding - Roche/Genentech (Inst)
 
Gun Min Kim
No Relationships to Disclose
 
Hyo Song Kim
No Relationships to Disclose
 
Jae-Ho Cheong
Consulting or Advisory Role - UAB Health System Foundation
Research Funding - UAB Health System Foundation
 
Young Woo Lee
Employment - Immunome
 
Barbara Jean Geiger
Consulting or Advisory Role - Immunome
 
Sanghee Yoo
Employment - Immunome
Leadership - Immunome
Stock and Other Ownership Interests - Immunome
 
Marc S. Rudoltz
Stock and Other Ownership Interests - MSR Healthcare Consultants LLC; Mycovia Pharmaceuticals; Novartis
Consulting or Advisory Role - Celgene; Daiichi Sankyo; Epivax Oncology
 
Filip Janku
Stock and Other Ownership Interests - Trovagene
Consulting or Advisory Role - Deciphera; Foundation Medicine; Guardant Health; IDEAYA Biosciences; IDEAYA Biosciences; IFM Therapeutics; Immunome; Jazz Pharmaceuticals; Novartis; PureTech; Sequenom; Sotio; Synlogic; Trovagene; Valeant/Dendreon
Research Funding - Agios (Inst); Asana Biosciences (Inst); Astellas Pharma (Inst); Astex Pharmaceuticals (Inst); BioMed Valley Discoveries (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Deciphera (Inst); Fujifilm (Inst); Genentech (Inst); Novartis (Inst); Piqur (Inst); Plexxikon (Inst); Proximagen (Inst); Roche (Inst); Symphogen (Inst)
Other Relationship - Bio-Rad